Neuberger Berman is an independent and employee-controlled asset management company, providing global investment solutions.
Business Model:
Revenue: $2B
Employees: 1,001-5,000
Neuberger Berman Group was acquired by
Lehman Brothers.
The acquisition happend on 2003-11-07.
Details of the transaction were not public
Address: 1290 Avenue of the Americas
City: New York
State: NY
Zip: 10104
Country: US
Neuberger Berman is an independent and employee-controlled asset management company, providing global investment solutions. Neuberger Berman provides a broad range of global investment solutions to institutions and individuals through customized separately managed accounts, mutual funds, and alternative investment products. It was founded in 1939 and headquartered in New York, United States.
Contact Phone:
+18002236448
Contact Email:
Listed Exchange:
NYSE
IPO Date:
10/7/1999
Ticker Symbol:
NEU
IPO Price:
$32/share
Amount Raised:
$232M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
8/2020 | Fanatics | Series E | 350M |
2/2020 | Level | Debt Financing | 100M |
12/2021 | Pear Therapeutics | Post-IPO Equity | 0 |
2/2021 | SolarWinds | Post-IPO Equity | - |
12/2011 | Counsyl | Private Equity Round | 54M |
6/2020 | Trustly | Venture Round | - |
8/2021 | Volta Charging | Post-IPO Equity | 300M |
2/2022 | Scipher Medicine | Series D | 0 |
7/2021 | Owlet Baby Care | Post-IPO Equity | 130M |
6/2021 | Proterra | Post-IPO Equity | 415M |
5/2021 | Caris Life Sciences | Private Equity Round | 0 |
5/2016 | Parag Milk Foods | Venture Round | 0 |
3/2015 | LookingGlass Cyber Solutions | Series B | 20M |
8/2021 | Li-Cycle | Post-IPO Equity | 0 |
10/2021 | PharmEasy | Venture Round | 0 |
3/2018 | CommonBond | Series D | 50M |
9/2020 | Skillz | Post-IPO Equity | 0 |
12/2019 | Duck Creek Technologies | Private Equity Round | 120M |
10/2020 | DoubleVerify | Private Equity Round | 350M |
8/2017 | LookingGlass Cyber Solutions | Series D | 26.3M |
6/2021 | Katapult | Post-IPO Equity | 150M |
12/2020 | IOU Financial | Post-IPO Equity | 2.1M |
4/2022 | Quantum | Post-IPO Equity | 67.5M |
1/2022 | Savage X Fenty | Series C | 0 |
10/2020 | Caris Life Sciences | Private Equity Round | 0 |
5/2021 | Akili Interactive Labs | Series D | 0 |
4/2020 | AvidXchange | Series F | 128M |
6/2019 | Druva | Series G | 0 |
6/2018 | Uniasselvi | Private Equity Round | 100M |
11/2022 | Prosper Marketplace | Debt Financing | 75M |
7/2016 | CommonBond | Series C | 30M |
8/2021 | Rocket Lab | Post-IPO Equity | 0 |
4/2021 | Druva | Series H | 147M |
5/2021 | Constellation Automotive Group | Private Equity Round | 1.4B |
7/2018 | LegalZoom | Secondary Market | 0 |
8/2021 | Branch | Debt Financing | 500M |
1/2021 | Paycor | Private Equity Round | 0 |
6/2021 | PLAYSTUDIOS | Post-IPO Equity | 250M |
2/2016 | Engineering Ingegneria Informatica | Post-IPO Equity | - |
8/2022 | USIC | Secondary Market | 0 |
5/2023 | NomuPay | Series A | 53.6M |
7/2021 | Finnish Long Drink | Funding Round | 25M |
7/2016 | Concord Biotech | Private Equity Round | - |
7/2021 | Sunlight Financial | Post-IPO Equity | 250M |
2/2021 | Koalafi | Debt Financing | - |
11/2016 | Velocidi | Series A | 0 |
8/2022 | Ribbon Communications | Post-IPO Equity | 52M |
7/2021 | Lucid Motors | Post-IPO Equity | 0 |
9/2022 | Oportun | Post-IPO Debt | 150M |
7/2021 | EVgo | Post-IPO Equity | 400M |
5/2015 | Basis Technologies | Series B | 30M |
3/2021 | ChargePoint | Post-IPO Equity | 225M |
10/2022 | Arctic Wolf | Convertible Note | 401M |
3/2021 | Fanatics | Private Equity Round | 320M |
12/2021 | Solid Power | Post-IPO Equity | 0 |
3/2022 | A24 | Private Equity Round | 0 |
4/2021 | Signifyd | Series E | 205M |
4/2022 | Salsify | Series F | 0 |
7/2017 | FV Hospital | Private Equity Round | - |
7/2022 | Supermojo | Seed Round | 0 |
11/2020 | Menlo Security | Series E | 100M |
5/2022 | Clutch | Debt Financing | 0 |
4/2015 | Prosper Marketplace | Series D | 0 |
8/2022 | Celonis | Series D | 0 |
7/2022 | Supermojo | Seed Round | 0 |
5/2022 | Clutch | Debt Financing | 0 |
4/2022 | Quantum | Post-IPO Equity | 0 |
4/2022 | Salsify | Series F | 0 |
3/2022 | A24 | Private Equity Round | 0 |
2/2022 | Scipher Medicine | Series D | 0 |
1/2022 | Savage X Fenty | Series C | 0 |
12/2021 | Solid Power | Post-IPO Equity | 0 |
12/2021 | Pear Therapeutics | Post-IPO Equity | 0 |
10/2021 | PharmEasy | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|